LGVN Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 23:00):

Stats
Dzisiejszy wolumen	395 492
Średni wolumen	2.17M
Kapitalizacja rynkowa	8.40M
EPS	$0 ( 2024-02-27 )
Następna data zysków	( $-2.01 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.170
ATR14	$0.00900 (0.51%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-11	Hare Joshua	Buy	42 553	Class A Common Stock
2024-04-10	Hare Joshua	Buy	106 383	Class A Common Stock
2024-04-10	Hare Joshua	Buy	106 383	Warrant (right to buy)
2024-04-11	Hare Joshua	Buy	42 553	Warrant (right to buy)
2024-04-11	Hashad Mohamed Wa'el Ahmed	Buy	10 638	Class A Common Stock

INSIDER POWER
39.60
Last 100 transactions
Buy: 1 179 927 \| Sell: 679 611

Wolumen Korelacja

Długi: 0.05 (neutral)

Krótki: 0.59 (weak)

Signal:(46.527) Neutral

Longeveron Inc. Class A Korelacja

10 Najbardziej pozytywne korelacje
EVOK	0.972
VVOS	0.97
UXIN	0.968
CNSP	0.963
KXIN	0.962
AYLA	0.961
RIDE	0.961
AGRI	0.957
ASLE	0.957
BCAN	0.955

10 Najbardziej negatywne korelacje
BRIVU	-0.956
MSDA	-0.955
SGII	-0.947
RNLC	-0.947
KRUS	-0.944
STAY	-0.944
MASI	-0.941
TIOAU	-0.941
INBKZ	-0.94
ADTH	-0.939

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Longeveron Inc. Class A Korelacja - Waluta/Towar

0.16
( neutral )

-0.11
( neutral )

0.00
( neutral )

0.64
( weak )

-0.63
( weak negative )

Longeveron Inc. Class A Finanse

Annual	2023
Przychody:	$709 000
Zysk brutto:	$-725 000 (-102.26 %)
EPS:	$-9.85

FY	2023
Przychody:	$709 000
Zysk brutto:	$-725 000 (-102.26 %)
EPS:	$-9.85

FY	2022
Przychody:	$1.22M
Zysk brutto:	$497 000 (40.67 %)
EPS:	$-9.36

FY	2021
Przychody:	$1.31M
Zysk brutto:	$590 000 (45.18 %)
EPS:	$-0.897

Financial Reports:

No articles found.

Longeveron Inc. Class A

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications, such as aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is based in Miami, Florida.

Aktualne aktualizacje dla Longeveron Inc. Class A [LGVN]

Upcoming Earnings Alert